BioNTech BNTX Shares, + 3.95% and Pfizer Inc. PFE, + 1.46% Both were launched into pre-market trade on Monday after companies said their experimental COVID-19 vaccine elicited a T-cell response in people participating in a phase 1/2 clinical trial in Germany. The vaccine candidate also again demonstrated that it can …
Read More »BioNTech, Pfizer Shares Meeting On Preliminary Data Showing Candidate T-Cell Response To Coronavirus Vaccine
